Developer docs
API playgroundTry for free, no card

Search company profiles

Rigaku Holdings

Full company profile

uuid0000fck

Namestring
Rigaku Holdings
Legal namestring
Rigaku Holdings Corporation (リガク・ホールディングス株式会社)
Company typeenum
Public
Founded yearint
1951
Descriptiontext

Rigaku Holdings Corporation (TSE Prime: 268A) is a 75-year-old Japanese pure-play manufacturer of X-ray analytical and metrology instrumentation, operating through its wholly owned subsidiary Rigaku Corporation and a global footprint of 9 operating countries serving customers in 136 markets. The company builds a vertically integrated portfolio spanning X-ray diffraction (XRD, including high-resolution SmartLab and the proprietary DD/patented Direct Derivation method), wavelength- and energy-dispersive X-ray fluorescence (WDXRF/EDXRF, including ZSX Primus, NEX QC II, WaferX 310 and the Niton handheld line), total-reflection XRF (TXRF 3760, XHEMIS TX-3000), X-ray computed tomography (nano3DX, CT Lab), small-angle X-ray scattering (SAXS, including the CD-SAXS XTRAIA CD-3200T), electron diffraction (XtaLAB Synergy-ED, co-developed with JEOL), Raman spectroscopy (Progeny, CQL ID, Icon-X handhelds), and thermal analysis (TG-DTA, DSC, STAvesta, TMA). It also sells Electron Density Topography (EDT/MoleQlyze) instruments for biopharmaceutical imaging and life-sciences preclinical imaging (PET/SPECT/CT) acquired via MILabs B.V.

The business model is anchored on one-time capital equipment sales of high-end analytical instruments, complemented by recurring aftermarket service, support, replacement parts, and consumables tied to a multi-decade installed base, plus a growing software/analytics stream (notably through the Ai Diffract integration with Onto Innovation for hybrid metrology). Customers are sold via direct enterprise field sales through regional headquarters in Japan, the Americas (The Woodlands, TX), EMEA (Germany) and Asia-Pacific (Singapore), supplemented by channel partnerships (Shimadzu in Japan), co-development alliances (JEOL for electron diffraction, Onto Innovation for hybrid semiconductor metrology, imec for next-generation device metrology), and distributor relationships for handheld security Raman. End markets are diversified across eight primary verticals — semiconductor (front-end and advanced packaging), batteries and power electronics, pharmaceuticals and life sciences, materials/metals/mining/cement, academia and government research, public safety/forensics, electronics components, and food/cosmetics/cultural heritage — with approximately 70% of revenue generated overseas. The group employs more than 2,000 people and manufactures at the Akishima (Tokyo), Yamanashi (capacity doubled in 2025), Osaka, Kyoto (Nihon Instruments mercury analyzers), Auburn Hills MI, Dolní Břežany (Czechia), and Migdal HaEmek (Israel) facilities.

Recent strategic activity is dominated by the April 2026 announcement of a capital and business alliance with Onto Innovation Inc., under which Onto will acquire a 27% stake (61,123,436 shares) from Carlyle affiliate Atom Investment, L.P. for approximately USD 710 million (expected close H2 2026), a three-year co-development program with imec targeting an estimated USD 1 billion serviceable available market by 2030 in advanced AI semiconductor metrology with a 50% share goal, a December 2025 product launch of the ONYX 3200 dual-head microfocus X-ray metrology system (with FY2026 sales target of JPY 1.5 billion rising to JPY 3 billion in FY2027), and a portfolio of follow-on launches (XTRAIA MF-3400, XHEMIS TX-3000, NEX QC II Series, Icon-X handheld Raman). The holding company was IPO'd on the Tokyo Stock Exchange Prime Market on October 25, 2024.

Short descriptiontext

Rigaku Holdings Corporation is a 75-year-old Japanese pure-play manufacturer of X-ray analytical, metrology, electron-diffraction, Raman and thermal-analysis instrumentation, serving global semiconductor, pharmaceutical, battery, life-sciences, materials, academic and public-safety customers through direct sales in 9 countries.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1,001–5,000
akta.pro rankint
HeadquartersAkishima, Japan
HQ citystring
Akishima
HQ countrystring
Japan
HQ regionstring
Asia
Markets served

Serves global market

Offices23 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
X-ray analytical instruments, semiconductor metrology equipment, X-ray diffraction systems, X-ray fluorescence spectrometry, electron diffraction analysis
Industry3 codes
1Mass Spectrometry & Spectroscopy Instruments
CodeHLAGAIABPrimaryYes
2Microscopy, Imaging & Flow Cytometry Instruments
CodeHLAGAIAEPrimaryNo
3Analytical Instruments & Chromatography Systems
CodeHLAGAIAAPrimaryNo
NAICS code2 codes
  • Irradiation Apparatus Manufacturing334517
  • Analytical Laboratory Instrument Manufacturing334516
SIC code2 codes
  • X-Ray Apparatus & Tubes & Related Irradiation Apparatus3844
  • Laboratory Analytical Instruments3826
Product category
X-ray analytical instrumentation
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model4 records
1Instrument sales (X-ray, electron, Raman, thermal analyzers)
TypeHardware Sales
Description

Primary revenue stream from one-time sale of capital equipment (XRD, XRF, X-ray CT, TXRF, SAXS, electron diffraction, Raman, thermal analyzers) to semiconductor fabs, foundries, research institutions, pharma and industrial customers globally.

rigaku-holdings.com
2Aftermarket service, support and consumables
TypeManaged Services
Description

Installation, training, application support, field service, replacement parts and consumables tied to the installed base across more than 136 countries.

rigaku-holdings.com
3Software and analytics licensing
TypeLicensing Royalties
Description

Licensing of analysis software (XtaLAB Synergy-ED suite, Ai Diffract integration with Onto Innovation, MoleQlyze/EDT analysis software) bundled with or sold alongside instruments.

rigaku-holdings.com
4Strategic equity monetization
TypeOne Time License
Description

27% equity stake acquisition by Onto Innovation for approximately USD 710 million (expected H2 2026 close) from Atom Investment, L.P. (Carlyle affiliate) - capital inflow and future governance/dividend participation.

rigaku-holdings.com
Marketing channels10 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels6 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales, Infrastructure
Pricing details1 tier
1Enterprise / quote-based capital equipment pricing
ModelOtherBilling cadenceMulti-year contract
Notes

Specific list prices not publicly disclosed; pricing negotiated per customer and configuration (e.g., ONYX 3200, XTRAIA series, NEX QC II series, TXRF systems, EDT/MoleQlyze). Sales target metrics (JPY 1.5B FY2026, JPY 3B FY2027 for ONYX 3200) indicate high-end capital pricing.

rigaku-holdings.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 7 records shown
1Rigaku
Description

Master corporate brand for the group's X-ray analysis, semiconductor metrology and life sciences instruments (used for both the holding company and the operating subsidiary).

rigaku-holdings.com
+6 more records
Core offering1 text field

Rigaku Holdings develops, manufactures, and sells X-ray-based analytical and metrology instrumentation, including X-ray diffraction (XRD), X-ray fluorescence (XRF), total-reflection XRF (TXRF), X-ray computed tomography (CT), small-angle X-ray scattering (SAXS), electron diffraction, Raman spectroscopy, and thermal analysis systems. These capital instruments are sold to semiconductor fabs and foundries, pharmaceutical and biopharmaceutical companies, academic and government research institutions, public-safety agencies, and industrial customers in more than 136 countries, complemented by aftermarket service, consumables, and bundled proprietary software.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • Target of approximately USD 1 billion SAM by 2030 in advanced AI semiconductor metrology with a 50% market share goal.
+4 more records
Product and service22 records
1SmartLab High-Resolution XRD
CategoryX-ray diffraction (XRD)
Description

High-resolution X-ray diffraction system for advanced materials characterization, including pharmaceutical polymorph identification and crystal structure analysis, used by pharmaceutical companies and academic research institutions.

2MiniFlex / MiniFlex XpC Benchtop XRD
CategoryX-ray diffraction (XRD)
Description

Benchtop X-ray diffraction instruments for routine qualitative and quantitative phase analysis in pharmaceutical and materials QA/QC workflows.

3Synergy Series Single-Crystal XRD
CategorySingle-crystal X-ray diffraction
Description

Single-crystal X-ray diffraction platforms for small-molecule and protein crystallography, supporting structure-based drug design and academic structural chemistry.

4XtaLAB Synergy-ED Electron Diffraction Platform
CategoryElectron diffraction
Description

Electron-diffraction integrated platform co-developed with JEOL for MicroED analysis of sub-micrometer crystals, enabling structural analysis of pharmaceutical polymorphs and protein microcrystals where conventional X-ray diffraction fails.

5MoleQlyze (Electron Density Topography)
CategoryLife-sciences electron density analysis
Description

Electron Density Topography (EDT) system for capturing the shape and motion of biomolecules (antibodies, protein complexes, viral particles) in solution as electron-density maps; supports antibody-drug and drug-delivery R&D.

6ZSX Primus Series WDXRF
CategoryWavelength-dispersive XRF (WDXRF)
Description

Wavelength-dispersive X-ray fluorescence spectrometers for elemental analysis of pharmaceuticals, steel, cement, ceramics, and minerals.

7NEX QC II / NEX QC II+ Benchtop EDXRF
CategoryEnergy-dispersive XRF (EDXRF)
Description

Second-generation benchtop energy-dispersive XRF analyzer with approximately 2.3x improved detection capability and 1/5 the measurement time of the prior NEX QC, designed for industrial quality control applications.

8NEX Series EDXRF Analyzers
CategoryEnergy-dispersive XRF (EDXRF)
Description

Energy-dispersive X-ray fluorescence analyzers spanning benchtop to process-analytical configurations for industrial QC and elemental impurity management.

9Niton Series Handheld XRF
CategoryHandheld XRF
Description

Portable handheld XRF analyzers for in-situ elemental analysis of batteries (recycling), metals, and coatings.

10XTRAIA XD Series Semiconductor XRD
CategorySemiconductor XRD
Description

High-resolution X-ray diffraction systems for epitaxial film strain, composition, thickness, and multi-layer thin-film analysis in semiconductor wafer manufacturing (includes XD-3000R mask variant).

11XTRAIA MF Series Semiconductor XRD
CategorySemiconductor XRD
Description

X-ray reflectometry and related thin-film measurement systems for blanket and patterned wafers; the MF-3000R targets photomask films and the MF-3400 (Dec 2025) targets next-generation AI/data-center devices.

12XTRAIA CD Series / CD-3200T CD-SAXS
CategorySemiconductor CD-SAXS
Description

Critical-dimension small-angle X-ray scattering (CD-SAXS) platforms for advanced logic and memory device shape measurement; CD-3200T integrates Onto Innovation's Ai Diffract analysis software for hybrid metrology.

13ONYX Series / ONYX 3200 Semiconductor Metrology
CategorySemiconductor metal-inspection metrology
Description

Dual-head microfocus X-ray metrology instruments; the ONYX 3200 enables complete metal inspection across chip wiring and advanced packaging on a single platform for AI/HPC/data-center foundry customers.

14WaferX 310 Semiconductor WDXRF
CategorySemiconductor WDXRF
Description

Wavelength-dispersive XRF spectrometer configured for measuring composition of blanket and patterned wafers in semiconductor manufacturing.

15TXRF Series / XHEMIS TX-3000
CategoryTotal-reflection XRF (TXRF)
Description

Total-reflection X-ray fluorescence analyzers for trace surface contamination and metal-contamination mapping on wafers and photomasks; the XHEMIS TX-3000 offers up to 6x higher throughput for advanced processes.

16nano3DX / CT Lab Series X-ray CT
CategoryX-ray computed tomography (CT)
Description

High-resolution X-ray CT systems for non-destructive 3D inspection of pharmaceutical tablets, electronic assemblies, batteries, ceramics, and food products.

17Cosmo Scan / Stella Scan Biological Imaging
CategoryPreclinical biological imaging
Description

PET/SPECT/optical/CT imaging systems originating from MILabs B.V., enabling in-vivo skeletal and organ imaging of small animals and biological-sample CT for drug-discovery safety and efficacy studies.

18Progeny / CQL ID Handheld Raman
CategoryHandheld Raman spectroscopy
Description

Portable Raman spectrometers for non-contact material verification through packaging, used for pharmaceutical raw-material acceptance and incoming-goods identity testing.

19Icon-X Handheld Raman Analyzer
CategorySecurity/disaster-response handheld Raman
Description

Handheld Raman analyzer for remote identification of hazardous chemicals, explosives, and narcotics for security forces and disaster response.

20TG-DTA / DSC Thermal Analysis Series
CategoryThermal analysis
Description

Simultaneous thermogravimetric/differential thermal analyzers and differential scanning calorimeters for pharmaceutical stability, polymer, ceramic, and metal characterization.

21STAvesta Thermal Analyzer
CategoryThermal analysis
Description

Next-generation simultaneous thermal analyzer launched July 2025 for advanced materials development.

22Shimadzu-co-sold X-ray Instruments with Shimadzu Software
CategoryChannel co-sold X-ray solutions
Description

Bundle of Rigaku X-ray instruments with Shimadzu analytical software for pharmaceutical, food, and chemical market customers in Japan.

Scale indicator10 records

Each record includes

Type, Value, Description, Source

Partnership11 partners
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2026-06-09
Description

Joint research with Shionogi, JEOL and Meiji Pharmaceutical University published in Crystal Growth & Design (June 2026) on the discovery of a new polymorph (κ-form) of indomethacin, using the XtaLAB Synergy-ED MicroED platform.

Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2026-05-12
Description

Three-year development program with Belgian semiconductor research organization imec, signed April 9, 2026 and announced May 12, 2026. Focus on advanced logic (CFET structures), reticle metrology (EUV mask degradation), advanced packaging non-destructive inspection, and next-generation memory (3D DRAM). Targets approximately USD 1B SAM by 2030 in AI semiconductor metrology with 50% market share goal.

Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2026-04-20
Description

Capital and business alliance announced April 20, 2026 in which Onto Innovation acquires 27% of Rigaku (61,123,436 shares) from Carlyle affiliate Atom Investment L.P. for approximately USD 710 million, expected to close H2 2026. Combines Rigaku's X-ray CD-SAXS with Onto's optical metrology and Ai Diffract AI software to develop hybrid metrology for advanced logic and memory devices. Rigaku targets at least USD 300M in incremental market opportunity by 2030 and gains the right to nominate one director.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-04-09
Description

Collaboration on Rigaku's EDT (Electron Density Topography) / MoleQlyze technology for antibody-drug and biopharmaceutical research. Includes establishment of an EDT user council (April 2026) and integration with the university's Research Infrastructure Sharing Center (J-PEAKS program).

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2024-11-28
Description

Co-located showroom laboratory opened in Cleveland, Ohio in November 2024 with Herzog to provide sample testing and joint development support to North American customers.

Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2021-10-28
Description

Co-selling and software collaboration partnership announced October 28, 2021 targeting pharmaceutical, food and chemical markets in Japan. Involves joint sale of Rigaku X-ray instruments and joint use of Shimadzu software.

Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2021-08-02
Description

Rigaku Corporation acquired all issued shares of MILabs B.V. on August 2, 2021 to enter the life sciences imaging business. MILabs brings PET, SPECT, optical imaging and CT equipment for animals, expanding Rigaku's global life-sciences modality offerings. MILabs now operates from Houten, Netherlands as a Rigaku subsidiary.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2021-05-25
Description

Joint development and launch of the XtaLAB Synergy-ED electron diffraction integrated platform, announced May 25, 2021. Used in the discovery of a new indomethacin polymorph (κ-form) published in Crystal Growth & Design (June 2026).

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Co-developed ULTGA, a specialized device for measuring CO2 fixation in concrete, with Prof. Ippei Maruyama (University of Tokyo) and verification by Taiheiyo Consultants, supported by NEDO Green Innovation Fund.

Strategic tierMinorTypeGTM or Marketing Partner
Description

Rigaku has been the sponsor of the Protein Society's Carl Brändén Award since 2007 and a sponsor of the Dorothy Crowfoot Hodgkin Award since 2024, supporting recognition of leading protein-structure scientists.

Strategic tierMinorTypeImplementation/ SI/ Consulting Partner
Description

Operation HOPLON partnership providing training, drug-identification technology and interdiction strategy support to internationalize efforts against transnational criminal organizations.

Recent move9 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight8 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Hitachi High-Tech manufactures electron microscopes, X-ray analytical instruments and semiconductor metrology tools, directly overlapping Rigaku's semiconductor and electron-based product portfolio for advanced packaging and failure-analysis customers.

TypeDirect peer
Description

Bruker's AXS division directly competes with Rigaku in X-ray diffraction (XRD), X-ray fluorescence (XRF) and single-crystal crystallography for pharma, materials and academic customers. Both companies serve semiconductor metrology and life-science imaging end markets with overlapping product lines.

TypeBroad incumbent
Description

Shimadzu is a major Japanese analytical-instrument OEM and an active co-selling/software partner with Rigaku in pharma, food and chemicals; its XRD, XRF, mass-spectrometry and chromatography portfolio overlaps with Rigaku's materials and pharma analysis lines.

TypeDirect peer
Description

Oxford Instruments supplies X-ray, electron and analytical tools for semiconductor, materials and life-science applications, overlapping with Rigaku's X-ray and electron-diffraction offerings and serving similar foundries and research institutions.

TypeDirect peer
Description

JEOL is both a co-development partner (XtaLAB Synergy-ED) and a direct competitor in electron microscopy and electron diffraction for semiconductor and life-science markets, particularly in Japan and East Asia.

TypeEmerging player
Description

Onto Innovation is Rigaku's new strategic shareholder (27% stake, ~USD 710M) and hybrid-metrology partner combining its optical CD metrology and Ai Diffract software with Rigaku's X-ray CD-SAXS; the partnership creates co-sell motion and an aligned product roadmap for advanced logic and memory fabs.

TypeBroad incumbent
Description

Thermo Fisher offers a broad analytical-instruments portfolio (XRD, XRF, Raman, electron microscopy, life-sciences imaging) that competes with Rigaku's XRD/XRF/life-sciences products as part of a much larger diversified portfolio across pharma, materials and semiconductor end markets.

TypeBroad incumbent
Description

KLA is the dominant semiconductor process-control and inspection vendor; while its portfolio is centered on optical and e-beam, KLA's growing footprint in advanced-packaging inspection creates an indirect competitive and partnership dynamic with Rigaku's ONYX and XTRAIA metrology lines.

TypeEmerging player
Description

B&W Tek (a Metrohm subsidiary) is a global handheld/portable Raman spectroscopy vendor that competes with Rigaku Analytical Devices in pharmaceutical raw-material verification, security and counter-narcotics handheld analyzers.

TypeDirect peer
Description

Malvern Panalytical is a leading global supplier of XRD, XRF and particle characterization instruments and is one of Rigaku's closest direct competitors in materials-analysis X-ray instrumentation, particularly in pharma, mining and cement markets.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat7 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment8 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile6 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration2 records

Each record includes

Title, Type, Description, Source

AI capability6 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature9 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles12 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries18 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Rigaku Holdings

X-ray analytical instrumentationrigaku-holdings.com

Rigaku Holdings Corporation is a 75-year-old Japanese pure-play manufacturer of X-ray analytical, metrology, electron-diffraction, Raman and thermal-analysis instrumentation, serving global semiconductor, pharmaceutical, battery, life-sciences, materials, academic and public-safety customers through direct sales in 9 countries.

What Rigaku Holdings does

Rigaku Holdings Corporation (TSE Prime: 268A) is a 75-year-old Japanese pure-play manufacturer of X-ray analytical and metrology instrumentation, operating through its wholly owned subsidiary Rigaku Corporation and a global footprint of 9 operating countries serving customers in 136 markets. The company builds a vertically integrated portfolio spanning X-ray diffraction (XRD, including high-resolution SmartLab and the proprietary DD/patented Direct Derivation method), wavelength- and energy-dispersive X-ray fluorescence (WDXRF/EDXRF, including ZSX Primus, NEX QC II, WaferX 310 and the Niton handheld line), total-reflection XRF (TXRF 3760, XHEMIS TX-3000), X-ray computed tomography (nano3DX, CT Lab), small-angle X-ray scattering (SAXS, including the CD-SAXS XTRAIA CD-3200T), electron diffraction (XtaLAB Synergy-ED, co-developed with JEOL), Raman spectroscopy (Progeny, CQL ID, Icon-X handhelds), and thermal analysis (TG-DTA, DSC, STAvesta, TMA). It also sells Electron Density Topography (EDT/MoleQlyze) instruments for biopharmaceutical imaging and life-sciences preclinical imaging (PET/SPECT/CT) acquired via MILabs B.V.

The business model is anchored on one-time capital equipment sales of high-end analytical instruments, complemented by recurring aftermarket service, support, replacement parts, and consumables tied to a multi-decade installed base, plus a growing software/analytics stream (notably through the Ai Diffract integration with Onto Innovation for hybrid metrology). Customers are sold via direct enterprise field sales through regional headquarters in Japan, the Americas (The Woodlands, TX), EMEA (Germany) and Asia-Pacific (Singapore), supplemented by channel partnerships (Shimadzu in Japan), co-development alliances (JEOL for electron diffraction, Onto Innovation for hybrid semiconductor metrology, imec for next-generation device metrology), and distributor relationships for handheld security Raman. End markets are diversified across eight primary verticals — semiconductor (front-end and advanced packaging), batteries and power electronics, pharmaceuticals and life sciences, materials/metals/mining/cement, academia and government research, public safety/forensics, electronics components, and food/cosmetics/cultural heritage — with approximately 70% of revenue generated overseas. The group employs more than 2,000 people and manufactures at the Akishima (Tokyo), Yamanashi (capacity doubled in 2025), Osaka, Kyoto (Nihon Instruments mercury analyzers), Auburn Hills MI, Dolní Břežany (Czechia), and Migdal HaEmek (Israel) facilities.

Recent strategic activity is dominated by the April 2026 announcement of a capital and business alliance with Onto Innovation Inc., under which Onto will acquire a 27% stake (61,123,436 shares) from Carlyle affiliate Atom Investment, L.P. for approximately USD 710 million (expected close H2 2026), a three-year co-development program with imec targeting an estimated USD 1 billion serviceable available market by 2030 in advanced AI semiconductor metrology with a 50% share goal, a December 2025 product launch of the ONYX 3200 dual-head microfocus X-ray metrology system (with FY2026 sales target of JPY 1.5 billion rising to JPY 3 billion in FY2027), and a portfolio of follow-on launches (XTRAIA MF-3400, XHEMIS TX-3000, NEX QC II Series, Icon-X handheld Raman). The holding company was IPO'd on the Tokyo Stock Exchange Prime Market on October 25, 2024.

Rigaku Holdings firmographics

Firmographics
Name
Rigaku Holdings
Legal name
Rigaku Holdings Corporation (リガク・ホールディングス株式会社)
Website
https://rigaku-holdings.com
Company type
Public
Founded year
1951
Operating status
Operating
Headcount range
1,001–5,000 employees
Short description
Rigaku Holdings Corporation is a 75-year-old Japanese pure-play manufacturer of X-ray analytical, metrology, electron-diffraction, Raman and thermal-analysis instrumentation, serving global semiconductor, pharmaceutical, battery, life-sciences, materials, academic and public-safety customers through direct sales in 9 countries.
Ownership category
akta.pro rank

Rigaku Holdings industry classification

Industry
Product category
X-ray analytical instrumentation
NAICS
Irradiation Apparatus Manufacturing (334517), Analytical Laboratory Instrument Manufacturing (334516)
SIC
X-Ray Apparatus & Tubes & Related Irradiation Apparatus (3844), Laboratory Analytical Instruments (3826)
akta.pro primary industry
Mass Spectrometry & Spectroscopy Instruments (HLAGAIAB)
akta.pro secondary industries
Microscopy, Imaging & Flow Cytometry Instruments (HLAGAIAE), Analytical Instruments & Chromatography Systems (HLAGAIAA)

Keywords

  • X-ray analytical instruments
  • Semiconductor metrology equipment
  • X-ray diffraction systems
  • X-ray fluorescence spectrometry
  • Electron diffraction analysis

Where Rigaku Holdings is headquartered

Location

Headquarters

HQ city
Akishima
HQ country
Japan
HQ region
Asia

Offices23 records

Markets served

Rigaku Holdings business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

  1. Instrument sales (X-ray, electron, Raman, thermal analyzers): Primary revenue stream from one-time sale of capital equipment (XRD, XRF, X-ray CT, TXRF, SAXS, electron diffraction, Raman, thermal analyzers) to semiconductor fabs, foundries, research institutions, pharma and industrial customers globally.
  2. Aftermarket service, support and consumables: Installation, training, application support, field service, replacement parts and consumables tied to the installed base across more than 136 countries.
  3. Software and analytics licensing: Licensing of analysis software (XtaLAB Synergy-ED suite, Ai Diffract integration with Onto Innovation, MoleQlyze/EDT analysis software) bundled with or sold alongside instruments.
  4. Strategic equity monetization: 27% equity stake acquisition by Onto Innovation for approximately USD 710 million (expected H2 2026 close) from Atom Investment, L.P. (Carlyle affiliate) - capital inflow and future governance/dividend participation.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractEnterprise / quote-based capital equipment pricing

Go-to-market motion1 record

Distribution channels6 records

Marketing channels10 records

Rigaku Holdings product offering

Product offering

Core offering

Rigaku Holdings develops, manufactures, and sells X-ray-based analytical and metrology instrumentation, including X-ray diffraction (XRD), X-ray fluorescence (XRF), total-reflection XRF (TXRF), X-ray computed tomography (CT), small-angle X-ray scattering (SAXS), electron diffraction, Raman spectroscopy, and thermal analysis systems. These capital instruments are sold to semiconductor fabs and foundries, pharmaceutical and biopharmaceutical companies, academic and government research institutions, public-safety agencies, and industrial customers in more than 136 countries, complemented by aftermarket service, consumables, and bundled proprietary software.

Differentiator

Problem solved

Functional benefit

Brands

  • Rigaku: Master corporate brand for the group's X-ray analysis, semiconductor metrology and life sciences instruments (used for both the holding company and the operating subsidiary).
  • Rigaku Analytical Devices
  • Applied Rigaku Technologies
  • Rigaku Innovative Technologies
  • Rigaku Semiconductor Instruments
  • MILabs
  • Nihon Instruments (日本インスツルメンツ)

Products and services

  • SmartLab High-Resolution XRD High-resolution X-ray diffraction system for advanced materials characterization, including pharmaceutical polymorph identification and crystal structure analysis, used by pharmaceutical companies and academic research institutions.
  • MiniFlex / MiniFlex XpC Benchtop XRD Benchtop X-ray diffraction instruments for routine qualitative and quantitative phase analysis in pharmaceutical and materials QA/QC workflows.
  • Synergy Series Single-Crystal XRD Single-crystal X-ray diffraction platforms for small-molecule and protein crystallography, supporting structure-based drug design and academic structural chemistry.
  • XtaLAB Synergy-ED Electron Diffraction Platform Electron-diffraction integrated platform co-developed with JEOL for MicroED analysis of sub-micrometer crystals, enabling structural analysis of pharmaceutical polymorphs and protein microcrystals where conventional X-ray diffraction fails.
  • MoleQlyze (Electron Density Topography) Electron Density Topography (EDT) system for capturing the shape and motion of biomolecules (antibodies, protein complexes, viral particles) in solution as electron-density maps; supports antibody-drug and drug-delivery R&D.
  • ZSX Primus Series WDXRF Wavelength-dispersive X-ray fluorescence spectrometers for elemental analysis of pharmaceuticals, steel, cement, ceramics, and minerals.
  • NEX QC II / NEX QC II+ Benchtop EDXRF Second-generation benchtop energy-dispersive XRF analyzer with approximately 2.3x improved detection capability and 1/5 the measurement time of the prior NEX QC, designed for industrial quality control applications.
  • NEX Series EDXRF Analyzers Energy-dispersive X-ray fluorescence analyzers spanning benchtop to process-analytical configurations for industrial QC and elemental impurity management.
  • Niton Series Handheld XRF Portable handheld XRF analyzers for in-situ elemental analysis of batteries (recycling), metals, and coatings.
  • XTRAIA XD Series Semiconductor XRD High-resolution X-ray diffraction systems for epitaxial film strain, composition, thickness, and multi-layer thin-film analysis in semiconductor wafer manufacturing (includes XD-3000R mask variant).
  • XTRAIA MF Series Semiconductor XRD X-ray reflectometry and related thin-film measurement systems for blanket and patterned wafers; the MF-3000R targets photomask films and the MF-3400 (Dec 2025) targets next-generation AI/data-center devices.
  • XTRAIA CD Series / CD-3200T CD-SAXS Critical-dimension small-angle X-ray scattering (CD-SAXS) platforms for advanced logic and memory device shape measurement; CD-3200T integrates Onto Innovation's Ai Diffract analysis software for hybrid metrology.
  • ONYX Series / ONYX 3200 Semiconductor Metrology Dual-head microfocus X-ray metrology instruments; the ONYX 3200 enables complete metal inspection across chip wiring and advanced packaging on a single platform for AI/HPC/data-center foundry customers.
  • WaferX 310 Semiconductor WDXRF Wavelength-dispersive XRF spectrometer configured for measuring composition of blanket and patterned wafers in semiconductor manufacturing.
  • TXRF Series / XHEMIS TX-3000 Total-reflection X-ray fluorescence analyzers for trace surface contamination and metal-contamination mapping on wafers and photomasks; the XHEMIS TX-3000 offers up to 6x higher throughput for advanced processes.
  • nano3DX / CT Lab Series X-ray CT High-resolution X-ray CT systems for non-destructive 3D inspection of pharmaceutical tablets, electronic assemblies, batteries, ceramics, and food products.
  • Cosmo Scan / Stella Scan Biological Imaging PET/SPECT/optical/CT imaging systems originating from MILabs B.V., enabling in-vivo skeletal and organ imaging of small animals and biological-sample CT for drug-discovery safety and efficacy studies.
  • Progeny / CQL ID Handheld Raman Portable Raman spectrometers for non-contact material verification through packaging, used for pharmaceutical raw-material acceptance and incoming-goods identity testing.
  • Icon-X Handheld Raman Analyzer Handheld Raman analyzer for remote identification of hazardous chemicals, explosives, and narcotics for security forces and disaster response.
  • TG-DTA / DSC Thermal Analysis Series Simultaneous thermogravimetric/differential thermal analyzers and differential scanning calorimeters for pharmaceutical stability, polymer, ceramic, and metal characterization.
  • STAvesta Thermal Analyzer Next-generation simultaneous thermal analyzer launched July 2025 for advanced materials development.
  • Shimadzu-co-sold X-ray Instruments with Shimadzu Software Bundle of Rigaku X-ray instruments with Shimadzu analytical software for pharmaceutical, food, and chemical market customers in Japan.

Quantifiable outcome

  • Target of approximately USD 1 billion SAM by 2030 in advanced AI semiconductor metrology with a 50% market share goal.
  • +4 more outcomes

Companies that use Rigaku Holdings

Customer profile

Named customers6 records

Segments8 records

Ideal customer profiles6 records

Rigaku Holdings technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration2 records

AI capability6 records

Feature9 records

Rigaku Holdings partnerships and signals

Strategic signal

Partnerships

Eleven partnerships are on record, tiered minor, flagship, core and major.

  • Shionogi & Co., Ltd. (塩野義製薬)minorStrategic or Co-development Partner · 9 June 2026Joint research with Shionogi, JEOL and Meiji Pharmaceutical University published in Crystal Growth & Design (June 2026) on the discovery of a new polymorph (κ-form) of indomethacin, using the XtaLAB Synergy-ED MicroED platform.
  • imecflagshipStrategic or Co-development Partner · 12 May 2026Three-year development program with Belgian semiconductor research organization imec, signed April 9, 2026 and announced May 12, 2026. Focus on advanced logic (CFET structures), reticle metrology (EUV mask degradation), advanced packaging non-destructive inspection, and next-generation memory (3D DRAM). Targets approximately USD 1B SAM by 2030 in AI semiconductor metrology with 50% market share goal.
  • Onto Innovation Inc.flagshipStrategic or Co-development Partner · 20 April 2026Capital and business alliance announced April 20, 2026 in which Onto Innovation acquires 27% of Rigaku (61,123,436 shares) from Carlyle affiliate Atom Investment L.P. for approximately USD 710 million, expected to close H2 2026. Combines Rigaku's X-ray CD-SAXS with Onto's optical metrology and Ai Diffract AI software to develop hybrid metrology for advanced logic and memory devices. Rigaku targets at least USD 300M in incremental market opportunity by 2030 and gains the right to nominate one director.
  • Osaka Metropolitan University (大阪公立大学) Graduate School of Pharmaceutical SciencescoreStrategic or Co-development Partner · 9 April 2026Collaboration on Rigaku's EDT (Electron Density Topography) / MoleQlyze technology for antibody-drug and biopharmaceutical research. Includes establishment of an EDT user council (April 2026) and integration with the university's Research Infrastructure Sharing Center (J-PEAKS program).
  • Herzog (US)minorStrategic or Co-development Partner · 28 November 2024Co-located showroom laboratory opened in Cleveland, Ohio in November 2024 with Herzog to provide sample testing and joint development support to North American customers.
  • Shimadzu CorporationcoreChannel Partner/ Reseller/ Distributor · 28 October 2021Co-selling and software collaboration partnership announced October 28, 2021 targeting pharmaceutical, food and chemical markets in Japan. Involves joint sale of Rigaku X-ray instruments and joint use of Shimadzu software.
  • MILabs B.V.majorStrategic or Co-development Partner · 2 August 2021Rigaku Corporation acquired all issued shares of MILabs B.V. on August 2, 2021 to enter the life sciences imaging business. MILabs brings PET, SPECT, optical imaging and CT equipment for animals, expanding Rigaku's global life-sciences modality offerings. MILabs now operates from Houten, Netherlands as a Rigaku subsidiary.
  • JEOL Ltd. (日本電子株式会社)coreStrategic or Co-development Partner · 25 May 2021Joint development and launch of the XtaLAB Synergy-ED electron diffraction integrated platform, announced May 25, 2021. Used in the discovery of a new indomethacin polymorph (κ-form) published in Crystal Growth & Design (June 2026).
  • University of Tokyo (東京大学) and Taiheiyo Consultants (株式会社太平洋コンサルタント)minorStrategic or Co-development PartnerCo-developed ULTGA, a specialized device for measuring CO2 fixation in concrete, with Prof. Ippei Maruyama (University of Tokyo) and verification by Taiheiyo Consultants, supported by NEDO Green Innovation Fund.
  • The Protein SocietyminorGTM or Marketing PartnerRigaku has been the sponsor of the Protein Society's Carl Brändén Award since 2007 and a sponsor of the Dorothy Crowfoot Hodgkin Award since 2024, supporting recognition of leading protein-structure scientists.
  • Florida International University (FIU) National Forensic Science Technology Center (NSFTC)minorImplementation/ SI/ Consulting PartnerOperation HOPLON partnership providing training, drug-identification technology and interdiction strategy support to internationalize efforts against transnational criminal organizations.

Scale indicators10 records

Recent moves9 records

Expansion highlights8 records

Rigaku Holdings competitors and assessment

Company assessment

Broad incumbents

  • Hitachi High-Tech: Hitachi High-Tech manufactures electron microscopes, X-ray analytical instruments and semiconductor metrology tools, directly overlapping Rigaku's semiconductor and electron-based product portfolio for advanced packaging and failure-analysis customers.
  • Shimadzu Corporation: Shimadzu is a major Japanese analytical-instrument OEM and an active co-selling/software partner with Rigaku in pharma, food and chemicals; its XRD, XRF, mass-spectrometry and chromatography portfolio overlaps with Rigaku's materials and pharma analysis lines.
  • Thermo Fisher Scientific: Thermo Fisher offers a broad analytical-instruments portfolio (XRD, XRF, Raman, electron microscopy, life-sciences imaging) that competes with Rigaku's XRD/XRF/life-sciences products as part of a much larger diversified portfolio across pharma, materials and semiconductor end markets.
  • KLA Corporation: KLA is the dominant semiconductor process-control and inspection vendor; while its portfolio is centered on optical and e-beam, KLA's growing footprint in advanced-packaging inspection creates an indirect competitive and partnership dynamic with Rigaku's ONYX and XTRAIA metrology lines.

Direct peers

  • Bruker Corporation: Bruker's AXS division directly competes with Rigaku in X-ray diffraction (XRD), X-ray fluorescence (XRF) and single-crystal crystallography for pharma, materials and academic customers. Both companies serve semiconductor metrology and life-science imaging end markets with overlapping product lines.
  • Oxford Instruments: Oxford Instruments supplies X-ray, electron and analytical tools for semiconductor, materials and life-science applications, overlapping with Rigaku's X-ray and electron-diffraction offerings and serving similar foundries and research institutions.
  • JEOL Ltd. JEOL is both a co-development partner (XtaLAB Synergy-ED) and a direct competitor in electron microscopy and electron diffraction for semiconductor and life-science markets, particularly in Japan and East Asia.
  • Malvern Panalytical (Spectris plc): Malvern Panalytical is a leading global supplier of XRD, XRF and particle characterization instruments and is one of Rigaku's closest direct competitors in materials-analysis X-ray instrumentation, particularly in pharma, mining and cement markets.

Emerging players

  • Onto Innovation: Onto Innovation is Rigaku's new strategic shareholder (27% stake, ~USD 710M) and hybrid-metrology partner combining its optical CD metrology and Ai Diffract software with Rigaku's X-ray CD-SAXS; the partnership creates co-sell motion and an aligned product roadmap for advanced logic and memory fabs.
  • B&W Tek / Metrohm: B&W Tek (a Metrohm subsidiary) is a global handheld/portable Raman spectroscopy vendor that competes with Rigaku Analytical Devices in pharmaceutical raw-material verification, security and counter-narcotics handheld analyzers.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat7 records

Key risks5 records

Key highlights6 records

Customer concentration

Rigaku Holdings social profiles

Digital presence

Rigaku Holdings compliance and trust

Trust signal

Compliance3 records

Rigaku Holdings financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Rigaku Holdings leadership team

Management profile

Number of profiles

Profiles12 records

Rigaku Holdings subsidiaries and ownership

Company hierarchy

Subsidiaries18 records

Rigaku Holdings funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Rigaku Holdings M&A and investment

M&A and investment

M&A2 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Rigaku Holdings

What does Rigaku Holdings do?

Rigaku Holdings develops, manufactures, and sells X-ray-based analytical and metrology instrumentation, including X-ray diffraction (XRD), X-ray fluorescence (XRF), total-reflection XRF (TXRF), X-ray computed tomography (CT), small-angle X-ray scattering (SAXS), electron diffraction, Raman spectroscopy, and thermal analysis systems. These capital instruments are sold to semiconductor fabs and foundries, pharmaceutical and biopharmaceutical companies, academic and government research institutions, public-safety agencies, and industrial customers in more than 136 countries, complemented by aftermarket service, consumables, and bundled proprietary software.

Is Rigaku Holdings a public or private company?

Rigaku Holdings is a public company. It is classified as public and is currently operating.

When was Rigaku Holdings founded?

Rigaku Holdings was founded in 1951. It employs 1,001 to 5,000 people.

Where is Rigaku Holdings based?

Rigaku Holdings is headquartered in Akishima, Japan, in the Asia region.

How does Rigaku Holdings make money?

Four revenue lines are on record. Instrument sales (X-ray, electron, Raman, thermal analyzers) is the primary driver. The others are aftermarket service, support and consumables, software and analytics licensing and strategic equity monetization.

Who are Rigaku Holdings's main competitors?

Broad incumbents on record are Hitachi High-Tech, Shimadzu Corporation, Thermo Fisher Scientific and KLA Corporation. Direct peers are Bruker Corporation, Oxford Instruments, JEOL Ltd. and Malvern Panalytical (Spectris plc). Emerging players are Onto Innovation and B&W Tek / Metrohm.

Does Rigaku Holdings have an API?

No public API is recorded for Rigaku Holdings.

What industry is Rigaku Holdings in?

Rigaku Holdings's product category is X-ray analytical instrumentation. Its primary akta.pro industry code is HLAGAIAB, Mass Spectrometry & Spectroscopy Instruments, with a secondary code of HLAGAIAE, Microscopy, Imaging & Flow Cytometry Instruments. Its NAICS code is 334517 and its SIC code is 3844.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
ITWebRigaku Launches CT Lab HR160 High-Resolution X-ray CT SystemRigaku launched the CT Lab HR160 high-resolution X-ray CT system, developed with Excillum, for battery, semiconductor, and advanced materials analysis. The system operates up to 160 kV and achieves 250 nm spatial resolution, enabling detailed non-destructive 3D imaging of fine internal structures.AETOSWireRigaku Launches CT Lab HR160 High-Resolution X-ray CT SystemRigaku launched the CT Lab HR160, a high-resolution X-ray CT system developed with Excillum for battery, semiconductor, and advanced materials analysis. The system operates up to 160 kV and achieves 250 nm spatial resolution, enabling detailed non-destructive 3D imaging of fine internal structures.The Canadian Press NewsRigaku Launches CT Lab HR160 High-Resolution X-ray CT SystemRigaku launched the CT Lab HR160 high-resolution X-ray CT system, developed with Excillum, for battery, semiconductor, and electronic component analysis. The system operates up to 160 kV and achieves 250 nm spatial resolution, enabling detailed non-destructive 3D imaging of internal structures.AijournRigaku to Showcase Advanced X-ray Metrology and Inspection Solutions at SEMICON Taiwan 2026Rigaku Group will exhibit advanced X-ray metrology and inspection solutions at SEMICON Taiwan 2026, September 2-4, 2026, at TaiNEX 1 and 2 in Taipei, booth N0592. Products include the XHENA AX-3000, XHEMIS WX-PLP310, XTRAIA MF and XD series, and the ONYX Series, all available for customer evaluation. The booth also highlights Rigaku's alliance with Onto Innovation and its 75th anniversary.Business Wire BlogRigaku to Showcase Advanced X-ray Metrology and Inspection Solutions at SEMICON Taiwan 2026Rigaku Group will exhibit at SEMICON Taiwan 2026, September 2-4, 2026, at TaiNEX 1 and 2 in Taipei, booth N0592, showcasing X-ray metrology and inspection solutions for advanced logic, HBM and advanced packaging. Products include the XHENA AX-3000, XHEMIS WX-PLP310, XTRAIA MF Series and ONYX Series, plus a strategic alliance with Onto Innovation.Interesting EngineeringSemiconductor X-ray metrology reveals unseen defects in complex chipsRigaku and Tohoku University launched the Co-Creation Research Institute for X-ray Metrology at Tohoku University in Sendai, Japan, on August 1, with an initial three-year term subject to extension. The institute will use Tohoku's NanoTerasu synchrotron facility to develop soft X-ray microstructure measurement and data analysis methods for semiconductor chips, alongside researcher training and credit-bearing courses.PrtimesGlobal SAXS Diffractometer Market Growing at 5.8% CAGR Through 2034 – PR TimesIntel Market Research projects the global SAXS Diffractometer market to grow from USD 320 million in 2025 to USD 520 million by 2034, driven by R&D investments in nanotechnology and pharmaceutical applications. Key manufacturers including Rigaku Corporation, Bruker Corporation, and Malvern Panalytical are leveraging advanced technologies to capture market share across academic, industrial, and biotech sectors.The Globe and MailONTO's $720 Million Rigaku Stake Opens a Major New X-Ray Growth AvenueOnto Innovation Inc. completed a $720 million purchase of a 27% minority stake in Rigaku Holdings to accelerate the joint development of next-generation X-ray process-control technology for semiconductor manufacturing. This strategic investment aims to broaden Onto's portfolio by integrating X-ray capabilities with its existing optical tools to address complex 3D transistor and advanced packaging structures. The move expands Onto's served market while leveraging strong liquidity, though the financial impact depends on future product qualification and customer adoption.MarketScreenerOnto Innovation Acquires 27% Stake in RigakuOnto Innovation Inc. has acquired a 27% stake in Rigaku. The article details Onto Innovation's business focus, product lines, and its position in the semiconductor industry.Stock TitanOnto Innovation Completes ~$720M Rigaku Stake AcquisitionOnto Innovation completed a strategic investment of approximately $720 million for a 27% stake in Rigaku Holdings Corporation, strengthening their collaboration on X-ray technologies for semiconductor manufacturing. This investment aims to support the development of next-generation process control solutions amid advancing semiconductor innovations.